NZ562002A - Novel adhesive compositions comprising phloroglucinol (1,3,5-trihydroxybenzene), manufacturing thereof, and applications thereof - Google Patents
Novel adhesive compositions comprising phloroglucinol (1,3,5-trihydroxybenzene), manufacturing thereof, and applications thereofInfo
- Publication number
- NZ562002A NZ562002A NZ562002A NZ56200206A NZ562002A NZ 562002 A NZ562002 A NZ 562002A NZ 562002 A NZ562002 A NZ 562002A NZ 56200206 A NZ56200206 A NZ 56200206A NZ 562002 A NZ562002 A NZ 562002A
- Authority
- NZ
- New Zealand
- Prior art keywords
- composition
- matter
- phloroglucinol
- cross
- adhesive
- Prior art date
Links
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 292
- 239000000853 adhesive Substances 0.000 title claims abstract description 286
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 60
- 239000000203 mixture Substances 0.000 title description 189
- UIFJOXOHICDFDO-UHFFFAOYSA-N benzene-1,3,5-triol Chemical compound OC1=CC(O)=CC(O)=C1.OC1=CC(O)=CC(O)=C1 UIFJOXOHICDFDO-UHFFFAOYSA-N 0.000 title description 9
- 229920000642 polymer Polymers 0.000 claims abstract description 160
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 146
- 150000003000 phloroglucinols Chemical class 0.000 claims abstract description 137
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 claims abstract description 119
- 229960001553 phloroglucinol Drugs 0.000 claims abstract description 119
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 claims abstract description 115
- 150000002500 ions Chemical class 0.000 claims abstract description 28
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 16
- 235000010443 alginic acid Nutrition 0.000 claims description 121
- 229920000615 alginic acid Polymers 0.000 claims description 121
- 238000000034 method Methods 0.000 claims description 97
- 239000003795 chemical substances by application Substances 0.000 claims description 90
- 229960001126 alginic acid Drugs 0.000 claims description 77
- 239000000783 alginic acid Substances 0.000 claims description 77
- 150000004781 alginic acids Chemical class 0.000 claims description 75
- 230000003213 activating effect Effects 0.000 claims description 70
- 238000007789 sealing Methods 0.000 claims description 55
- -1 halogen salt Chemical class 0.000 claims description 50
- 241001465754 Metazoa Species 0.000 claims description 43
- 238000004132 cross linking Methods 0.000 claims description 35
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 32
- 150000003839 salts Chemical group 0.000 claims description 30
- 229910052736 halogen Inorganic materials 0.000 claims description 29
- 239000000178 monomer Substances 0.000 claims description 28
- 108090000790 Enzymes Proteins 0.000 claims description 24
- 102000004190 Enzymes Human genes 0.000 claims description 24
- 239000000565 sealant Substances 0.000 claims description 23
- 239000007800 oxidant agent Substances 0.000 claims description 22
- 239000003814 drug Substances 0.000 claims description 20
- 150000001720 carbohydrates Chemical class 0.000 claims description 19
- 229910001424 calcium ion Inorganic materials 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 17
- AEMOLEFTQBMNLQ-ORELYVPDSA-N alpha-L-glucopyranuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-ORELYVPDSA-N 0.000 claims description 15
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 239000005022 packaging material Substances 0.000 claims description 9
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 description 123
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 102
- 239000000243 solution Substances 0.000 description 79
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 70
- 108010073997 Bromide peroxidase Proteins 0.000 description 49
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 46
- 102000008186 Collagen Human genes 0.000 description 44
- 108010035532 Collagen Proteins 0.000 description 44
- 229920001436 collagen Polymers 0.000 description 44
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 39
- 235000010413 sodium alginate Nutrition 0.000 description 38
- 239000000661 sodium alginate Substances 0.000 description 38
- 229940005550 sodium alginate Drugs 0.000 description 38
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 37
- 229940072056 alginate Drugs 0.000 description 37
- 229920002799 BoPET Polymers 0.000 description 36
- 239000005041 Mylar™ Substances 0.000 description 36
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 34
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 30
- 239000000126 substance Substances 0.000 description 29
- 230000036541 health Effects 0.000 description 28
- 239000001110 calcium chloride Substances 0.000 description 26
- 229910001628 calcium chloride Inorganic materials 0.000 description 26
- 239000000463 material Substances 0.000 description 20
- 235000011148 calcium chloride Nutrition 0.000 description 18
- 229960002713 calcium chloride Drugs 0.000 description 18
- 239000000227 bioadhesive Substances 0.000 description 16
- 229910000019 calcium carbonate Inorganic materials 0.000 description 15
- 150000008442 polyphenolic compounds Chemical class 0.000 description 15
- 235000013824 polyphenols Nutrition 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 239000003292 glue Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 235000014633 carbohydrates Nutrition 0.000 description 13
- 239000012530 fluid Substances 0.000 description 13
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- 239000004793 Polystyrene Substances 0.000 description 12
- 239000011521 glass Substances 0.000 description 12
- 229920002223 polystyrene Polymers 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 229910052783 alkali metal Inorganic materials 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 10
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 9
- 238000009864 tensile test Methods 0.000 description 9
- 239000011575 calcium Substances 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 229920001282 polysaccharide Polymers 0.000 description 8
- 239000005017 polysaccharide Substances 0.000 description 8
- 150000004804 polysaccharides Chemical class 0.000 description 8
- 239000011550 stock solution Substances 0.000 description 8
- 230000003592 biomimetic effect Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000011777 magnesium Substances 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000003106 tissue adhesive Substances 0.000 description 6
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 5
- 102000003992 Peroxidases Human genes 0.000 description 5
- 238000011065 in-situ storage Methods 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 150000002978 peroxides Chemical class 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 150000002989 phenols Chemical class 0.000 description 5
- 125000002444 phloroglucinyl group Chemical group [H]OC1=C([H])C(O[H])=C(*)C(O[H])=C1[H] 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 235000010408 potassium alginate Nutrition 0.000 description 5
- 239000000737 potassium alginate Substances 0.000 description 5
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 241000195493 Cryptophyta Species 0.000 description 4
- 229920001651 Cyanoacrylate Polymers 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 241000237536 Mytilus edulis Species 0.000 description 4
- 206010034203 Pectus Carinatum Diseases 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000020638 mussel Nutrition 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000012286 potassium permanganate Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229910001631 strontium chloride Inorganic materials 0.000 description 4
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229940075469 tissue adhesives Drugs 0.000 description 4
- 239000012808 vapor phase Substances 0.000 description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 241000199919 Phaeophyceae Species 0.000 description 3
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 3
- 229910001626 barium chloride Inorganic materials 0.000 description 3
- 229910001422 barium ion Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000007385 chemical modification Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 3
- 239000000412 dendrimer Substances 0.000 description 3
- 229920000736 dendritic polymer Polymers 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 229910001425 magnesium ion Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 108010004563 mussel adhesive protein Proteins 0.000 description 3
- 239000011368 organic material Substances 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000009518 sodium iodide Nutrition 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 229910001427 strontium ion Inorganic materials 0.000 description 3
- 239000013638 trimer Substances 0.000 description 3
- LKUDPHPHKOZXCD-UHFFFAOYSA-N 1,3,5-trimethoxybenzene Chemical compound COC1=CC(OC)=CC(OC)=C1 LKUDPHPHKOZXCD-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 239000004826 Synthetic adhesive Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
- 230000010062 adhesion mechanism Effects 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 238000010954 commercial manufacturing process Methods 0.000 description 2
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 230000005661 hydrophobic surface Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 125000002081 peroxide group Chemical group 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000238586 Cirripedia Species 0.000 description 1
- 241001491621 Corallina officinalis Species 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 241000195480 Fucus Species 0.000 description 1
- 241000004454 Fucus serratus Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 101150054830 S100A6 gene Proteins 0.000 description 1
- 241000131858 Siboglinidae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical group C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- CHVJITGCYZJHLR-UHFFFAOYSA-N cyclohepta-1,3,5-triene Chemical compound C1C=CC=CC=C1 CHVJITGCYZJHLR-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- SOCTUWSJJQCPFX-UHFFFAOYSA-N dichromate(2-) Chemical compound [O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O SOCTUWSJJQCPFX-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000003380 quartz crystal microbalance Methods 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0005—Ingredients of undetermined constitution or reaction products thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J105/00—Adhesives based on polysaccharides or on their derivatives, not provided for in groups C09J101/00 or C09J103/00
- C09J105/04—Alginic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
- C08L2666/02—Organic macromolecular compounds, natural resins, waxes or and bituminous materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Dental Preparations (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Sealing Material Composition (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65741305P | 2005-03-02 | 2005-03-02 | |
| PCT/IL2006/000289 WO2006092798A2 (en) | 2005-03-02 | 2006-03-02 | Novel adhesive materials, manufacturing thereof, and applications thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ562002A true NZ562002A (en) | 2010-05-28 |
Family
ID=36609613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ562002A NZ562002A (en) | 2005-03-02 | 2006-03-02 | Novel adhesive compositions comprising phloroglucinol (1,3,5-trihydroxybenzene), manufacturing thereof, and applications thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8829075B2 (https=) |
| EP (1) | EP1863879B1 (https=) |
| JP (1) | JP5343279B2 (https=) |
| AT (1) | ATE494333T1 (https=) |
| AU (1) | AU2006219568B2 (https=) |
| CA (1) | CA2599785C (https=) |
| DE (1) | DE602006019392D1 (https=) |
| NZ (1) | NZ562002A (https=) |
| WO (1) | WO2006092798A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7364565B2 (en) | 2001-07-27 | 2008-04-29 | Ramot At Tel Aviv University Ltd. | Controlled enzymatic removal and retrieval of cells |
| EP1863879B1 (en) | 2005-03-02 | 2011-01-05 | Technion Research & Development Foundation Limited | Adhesive materials, manufacturing thereof, and applications thereof |
| US8673354B2 (en) * | 2007-11-05 | 2014-03-18 | Technion Research And Development Foundation Ltd. | Adhesives and methods of applying the same |
| EP2437797B1 (en) | 2009-06-01 | 2013-08-14 | Technion Research & Development Foundation Ltd. | Multi components adhesives, manufacturing thereof, and applications thereof |
| US8672957B2 (en) | 2011-07-28 | 2014-03-18 | Sealantis Ltd. | Adhesive patch vascular applicator |
| EP2550921B1 (en) | 2011-07-28 | 2013-09-11 | SEAlantis Ltd. | Adhesive patch vascular applicator |
| JP6041132B2 (ja) * | 2012-10-19 | 2016-12-07 | 国立研究開発法人国立循環器病研究センター | 材料表面修飾方法 |
| US20160174986A1 (en) * | 2014-07-02 | 2016-06-23 | The Cleveland Clinic Foundation | Anastomosis devices and methods of using same |
| US12102729B2 (en) | 2017-08-04 | 2024-10-01 | Hcs Innovation, Llc | Natural polymer-based tissue adhesive with healing-promoting properties |
| US11571492B2 (en) | 2017-08-04 | 2023-02-07 | Hcs Innovation, Llc | Natural polymer-based tissue adhesive with healing-promoting properties |
| US10835635B2 (en) | 2017-08-04 | 2020-11-17 | Hcs Innovation, Llc | Natural polymer based tissue adhesive with healing promoting properties |
| EP3801654B1 (en) * | 2018-05-31 | 2025-12-10 | Hcs Innovation Llc | Natural polymer-based tissue adhesive with healing-promoting properties |
| CN112898934B (zh) * | 2021-03-01 | 2023-03-31 | 重庆坤飞建设(集团)有限公司 | 一种装配式建筑耐候密封胶及其制备方法 |
| JP7838354B2 (ja) * | 2022-03-28 | 2026-04-01 | コニカミノルタ株式会社 | 難燃性樹脂組成物及び難燃性樹脂筐体 |
| CN115581795B (zh) * | 2022-10-27 | 2023-08-18 | 清泽医疗科技(广东)有限公司 | 抗菌软组织粘合保护剂及其制备方法和应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR804128A (fr) * | 1935-03-23 | 1936-10-16 | Du Pont Rayon Co | Colle et procédé en comportant application, pour augmenter le pouvoir adhésif du caoutchouc et d'autres substances |
| US2884389A (en) * | 1957-08-02 | 1959-04-28 | Koppers Co Inc | Method of preparing an adhesive which comprises reacting gelatinized and ungelatinized starch, a phenolic compound and an aldehyde |
| US3802897A (en) * | 1973-02-23 | 1974-04-09 | Anheuser Busch | Water resistant starch adhesive |
| DE2502429C3 (de) * | 1975-01-22 | 1979-06-21 | Akzo Gmbh, 5600 Wuppertal | Verfahren zur Herstellung von Phloroglucin |
| JPS6490118A (en) * | 1987-09-30 | 1989-04-06 | Lion Corp | Deodorizing composition |
| JPH04237476A (ja) * | 1991-01-11 | 1992-08-25 | Meiji Milk Prod Co Ltd | 生肉片類の接着方法 |
| JP2613148B2 (ja) * | 1992-02-28 | 1997-05-21 | 日本コーンスターチ株式会社 | 段ボール用澱粉系接着剤 |
| US5520727A (en) * | 1993-08-16 | 1996-05-28 | The Regents Of University Of California | Aqueous algal-based phenolic type adhesives and glues |
| US6214331B1 (en) * | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
| US20040018241A1 (en) * | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
| US6146497A (en) * | 1998-01-16 | 2000-11-14 | Hercules Incorporated | Adhesives and resins, and processes for their production |
| AU750706B2 (en) * | 1998-04-13 | 2002-07-25 | Rohm And Haas Company | Method of catalytic crosslinking of polymer and two-pack composition used therein |
| JP2001115120A (ja) * | 1999-10-19 | 2001-04-24 | Oji Paper Co Ltd | 段ボール用耐水接着剤 |
| ATE425776T1 (de) * | 2000-04-28 | 2009-04-15 | Fziomed Inc | Haemostatische zusammenstellung von polysauren und polyalkylenoxyden und deren verwendungsmethoden |
| WO2002036705A1 (de) * | 2000-11-06 | 2002-05-10 | Bayer Aktiengesellschaft | Selbstklebemasse |
| CA2351253A1 (en) * | 2000-11-10 | 2002-05-10 | Groupe Lysac Inc./Lysac Group Inc. | Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbent |
| EP1863879B1 (en) | 2005-03-02 | 2011-01-05 | Technion Research & Development Foundation Limited | Adhesive materials, manufacturing thereof, and applications thereof |
| US20060269480A1 (en) * | 2005-05-31 | 2006-11-30 | Ramot At Tel Aviv University Ltd. | Multi-triggered self-immolative dendritic compounds |
-
2006
- 2006-03-02 EP EP06711271A patent/EP1863879B1/en not_active Expired - Lifetime
- 2006-03-02 AU AU2006219568A patent/AU2006219568B2/en not_active Ceased
- 2006-03-02 WO PCT/IL2006/000289 patent/WO2006092798A2/en not_active Ceased
- 2006-03-02 JP JP2007557669A patent/JP5343279B2/ja not_active Expired - Lifetime
- 2006-03-02 NZ NZ562002A patent/NZ562002A/en not_active IP Right Cessation
- 2006-03-02 DE DE602006019392T patent/DE602006019392D1/de not_active Expired - Lifetime
- 2006-03-02 AT AT06711271T patent/ATE494333T1/de not_active IP Right Cessation
- 2006-03-02 US US11/885,555 patent/US8829075B2/en active Active - Reinstated
- 2006-03-02 CA CA2599785A patent/CA2599785C/en not_active Expired - Fee Related
-
2014
- 2014-09-08 US US14/479,798 patent/US9572908B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2599785A1 (en) | 2006-09-08 |
| WO2006092798A2 (en) | 2006-09-08 |
| US9572908B2 (en) | 2017-02-21 |
| EP1863879A2 (en) | 2007-12-12 |
| DE602006019392D1 (de) | 2011-02-17 |
| AU2006219568B2 (en) | 2011-09-15 |
| EP1863879B1 (en) | 2011-01-05 |
| US20140377208A1 (en) | 2014-12-25 |
| US20080167400A1 (en) | 2008-07-10 |
| JP5343279B2 (ja) | 2013-11-13 |
| ATE494333T1 (de) | 2011-01-15 |
| WO2006092798A3 (en) | 2007-08-02 |
| CA2599785C (en) | 2014-05-06 |
| JP2008536958A (ja) | 2008-09-11 |
| US8829075B2 (en) | 2014-09-09 |
| AU2006219568A1 (en) | 2006-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9572908B2 (en) | Manufacturing and applications of adhesive materials | |
| Han et al. | Biofilm-inspired adhesive and antibacterial hydrogel with tough tissue integration performance for sealing hemostasis and wound healing | |
| Nam et al. | Polymeric tissue adhesives | |
| Yan et al. | Preparation of mussel-inspired injectable hydrogels based on dual-functionalized alginate with improved adhesive, self-healing, and mechanical properties | |
| Jain et al. | Recent developments and clinical applications of surgical glues: An overview | |
| EP2249884B1 (en) | Adhering bandage and methods of applying the same | |
| Di Lena | Hemostatic polymers: the concept, state of the art and perspectives | |
| CA2637794C (en) | Adhesive for medical applications and means for haemostasis | |
| CN101716366A (zh) | 醛改性海藻酸钠和胺改性明胶的生物胶型止血剂 | |
| KR101804501B1 (ko) | 카테콜 기를 가지는 감마 폴리글루탐산, 이의 제조 방법 및 이를 포함하는 조직 접착제 | |
| CN114425103B (zh) | 一种仿生生物胶及其制备方法与应用 | |
| Liu et al. | A mussel inspired polyvinyl alcohol/collagen/tannic acid bioadhesive for wet adhesion and hemostasis | |
| CN112876597B (zh) | 一种交联剂、生物粘合剂及其制备方法和应用 | |
| CN118141973A (zh) | 一种用于止血的可注射水凝胶粘合剂及其制备方法和应用 | |
| CN115515652A (zh) | 一种医用水凝胶及其制备方法和用途 | |
| IL185658A (en) | Adhesive materials, manufacture thereof and applications thereof | |
| Cai et al. | Marine organism-inspired tough and adhesive patch based on thermosensitive quaternized chitin for tissue sealing/repair and hemostasis | |
| CN115252880B (zh) | 一种基于相分离的生物胶水及其制备方法和应用 | |
| Zeng et al. | Injectable Hydrogel Adhesive with Rapid In Situ Gelation and Robust Tissue Adhesion for Emergency Hemorrhage Control | |
| JP2023161851A (ja) | 接着剤、創傷被覆材、癒着防止材、止血材、シーラント、及び噴霧キット | |
| CN115160599A (zh) | 一种按需降解的聚多巴胺交联聚乙二醇水凝胶材料及其制备方法与应用 | |
| Cao et al. | A self-gelling hemostatic powder driven by hydrogen bonding and electrostatic interactions with antibacterial and antioxidant properties | |
| JP2025039022A (ja) | 接着剤、創傷被覆材、癒着防止材、止血材、シーラント、及び充填剤 | |
| KR20250101567A (ko) | 젤라틴과 카올린의 융합을 통해 제조된 체내 흡수성 지혈조성물 및 그 제조방법 | |
| CN119564918A (zh) | 一种含多酚的医用粘合剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 02 MAR 2016 BY HENRY HUGHES Effective date: 20130117 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 MAR 2017 BY DENNEMEYER + CO Effective date: 20160225 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 02 MAR 2018 BY DENNEMEYER + CO Effective date: 20170224 |
|
| LAPS | Patent lapsed |